Valuation Decoy Therapeutics Inc. London S.E.

Stocks

End-of-day quote London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

08-12	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	21.65	22.39	3.485	2.56	2.652	4.142
Change	-	3.4%	-84.43%	-26.55%	3.58%	56.21%
Enterprise Value (EV) ¹	11.01	-6.823	-8.621	-3.05	0.4389	-6.568
Change	-	-161.96%	-26.35%	64.62%	114.39%	-1,596.36%
P/E	-	-	-	-	-	-0.06x
PBR	-	0.58x	-	-	-	0.7x
PEG	-	-	-	-	-	-
Capitalization / Revenue	4.14x	12.2x	-	-	-	-
EV / Revenue	2.1x	-3.71x	-	-	-	-
EV / EBITDA	-1.42x	0.53x	0.38x	0.24x	-0.08x	1.61x
EV / EBIT	-1.41x	0.53x	0.38x	0.24x	-0.08x	1.6x
EV / FCF	-1.26x	1.76x	0.6x	0.34x	-0.15x	-3.6x
FCF Yield	-79.6%	57%	167%	295%	-674%	-27.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-129.1
Distribution rate	-	-	-	-	-	-
Net sales ¹	5.233	1.84	-	-	-	-
EBITDA ¹	-7.768	-12.79	-22.97	-12.88	-5.73	-4.089
EBIT ¹	-7.786	-12.81	-22.98	-12.89	-5.734	-4.096
Net income ¹	-7.352	-12.77	-31.61	-12.54	-5.576	-12.52
Net Debt ¹	-10.64	-29.21	-12.11	-5.61	-2.213	-10.71
Reference price ²	32,759.974	17,841.586	2,203.200	936.000	331.200	7.786
Nbr of stocks (in thousands)	0.66	1.26	1.58	2.74	8.01	532
Announcement Date	3/18/21	3/25/22	3/27/23	3/22/24	3/21/25	3/31/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.62x	7.16x	14.45x	1.43%	69.02B
ARGENX SE	37.68x	9.86x	30.11x	0.04%	66.32B
INSMED INCORPORATED	-77.54x	14.97x	-72.18x	-.--%	27.66B
BIONTECH SE	-15.71x	6.02x	-7.56x	-.--%	25.84B
WUXI BIOLOGICS (CAYMAN) INC.	30.64x	6.56x	17.04x	-.--%	26.54B
GENMAB A/S	27.79x	5.19x	17.27x	-.--%	20.4B
PHARMAESSENTIA CORPORATION	50.92x	18.81x	38.16x	0.3%	17.63B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1308.71x	37.87x	826.39x	-.--%	15.15B
EXELIXIS, INC.	18.26x	5.45x	12.72x	-.--%	14.65B
Average	155.71x	12.43x	97.38x	0.2%	31.47B
Weighted average by Cap.	83.82x	10.53x	52.90x	0.37%